NCT05330104View on ClinicalTrials.gov

SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

January 3, 2026

Study Completion Date

January 3, 2027

Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
BEHAVIORAL

Mobile Ecological Momentary Assessment

mEMA is a tool that allows for scheduled or triggered surveys to assess a participant's CIPN symptoms and/or fall risk

Trial Locations (1)

55447

Abbott Northwestern Hospital, Minneapolis

All Listed Sponsors
lead

Allina Health System

OTHER